Matches in SemOpenAlex for { <https://semopenalex.org/work/W2982346646> ?p ?o ?g. }
- W2982346646 endingPage "540" @default.
- W2982346646 startingPage "531" @default.
- W2982346646 abstract "Background Staging newly diagnosed breast cancer by using dynamic contrast material–enhanced MRI is limited by access, high cost, and false-positive findings. The utility of contrast-enhanced mammography (CEM) and 99mTc sestamibi–based molecular breast imaging (MBI) in this setting is largely unknown. Purpose To compare extent-of-disease assessments by using MRI, CEM, and MBI versus pathology in women with breast cancer. Materials and Methods In this HIPAA-compliant prospective study, women with biopsy-proven breast cancer underwent MRI, CEM, and MBI between October 2014 and April 2018. Eight radiologists independently interpreted each examination result prospectively and were blinded to interpretations of findings with the other modalities. Visibility of index malignancies, lesion size, and additional suspicious lesions (malignant or benign) were compared during pathology review. Accuracy of index lesion sizing and detection of additional lesions in women without neoadjuvant chemotherapy were compared. Results A total of 102 women were enrolled and 99 completed the study protocol (mean age, 51 years ± 11 [standard deviation]; range, 32–77 years). Lumpectomy or mastectomy was performed in 71 women (79 index malignancies) without neoadjuvant chemotherapy and in 28 women (31 index malignancies) with neoadjuvant chemotherapy. Of the 110 index malignancies, MRI, CEM, and MBI depicted 102 (93%; 95% confidence interval [CI]: 86%, 97%), 100 (91%; 95% CI: 84%, 96%), and 101 (92%; 95% CI: 85%, 96%) malignancies, respectively. In patients without neoadjuvant chemotherapy, pathologic size of index malignancies was overestimated with all modalities (P = .02). MRI led to overestimation of 24% (17 of 72) of malignancies by more than 1.5 cm compared with 11% (eight of 70) with CEM and 15% (11 of 72) with MBI. MRI depicted more (P = .007) nonindex lesions, with sensitivity similar to that of CEM or MBI, resulting in lower positive predictive value of additional biopsies (13 of 46 [28%; 95% CI: 17%, 44%] for MRI; 14 of 27 [52%; 95% CI: 32%, 71%] for CEM; and 11 of 25 [44%; 95% CI: 24%, 65%] for MBI (overall P = .01). Conclusion Contrast-enhanced mammography, molecular breast imaging, and MRI showed similar detection of all malignancies. MRI depicted more nonindex suspicious benign lesions than did contrast-enhanced mammography or molecular breast imaging, leading to lower positive predictive value of additional biopsies. All three modalities led to overestimation of index tumor size, particularly MRI. © RSNA, 2019 Online supplemental material is available for this article." @default.
- W2982346646 created "2019-11-08" @default.
- W2982346646 creator A5001080493 @default.
- W2982346646 creator A5004426985 @default.
- W2982346646 creator A5010411664 @default.
- W2982346646 creator A5028928157 @default.
- W2982346646 creator A5031316574 @default.
- W2982346646 creator A5054344119 @default.
- W2982346646 creator A5057889376 @default.
- W2982346646 creator A5058277289 @default.
- W2982346646 creator A5059049132 @default.
- W2982346646 creator A5060092330 @default.
- W2982346646 creator A5060609060 @default.
- W2982346646 creator A5076868240 @default.
- W2982346646 date "2019-12-01" @default.
- W2982346646 modified "2023-10-12" @default.
- W2982346646 title "Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer" @default.
- W2982346646 cites W1497326588 @default.
- W2982346646 cites W1559820277 @default.
- W2982346646 cites W1705216495 @default.
- W2982346646 cites W1884592785 @default.
- W2982346646 cites W1918479694 @default.
- W2982346646 cites W1974967625 @default.
- W2982346646 cites W1977476342 @default.
- W2982346646 cites W1998550745 @default.
- W2982346646 cites W1999247326 @default.
- W2982346646 cites W2003188860 @default.
- W2982346646 cites W2004432948 @default.
- W2982346646 cites W2006441555 @default.
- W2982346646 cites W2010115307 @default.
- W2982346646 cites W2013504058 @default.
- W2982346646 cites W2024847974 @default.
- W2982346646 cites W2026844494 @default.
- W2982346646 cites W2041956645 @default.
- W2982346646 cites W2079092071 @default.
- W2982346646 cites W2082337278 @default.
- W2982346646 cites W2086564414 @default.
- W2982346646 cites W2100115519 @default.
- W2982346646 cites W2103236551 @default.
- W2982346646 cites W2109909368 @default.
- W2982346646 cites W2113649907 @default.
- W2982346646 cites W2115164395 @default.
- W2982346646 cites W2122647939 @default.
- W2982346646 cites W2137181475 @default.
- W2982346646 cites W2141546864 @default.
- W2982346646 cites W2142144487 @default.
- W2982346646 cites W2147731364 @default.
- W2982346646 cites W2153626806 @default.
- W2982346646 cites W2153702945 @default.
- W2982346646 cites W2155852119 @default.
- W2982346646 cites W2162460750 @default.
- W2982346646 cites W2319962899 @default.
- W2982346646 cites W2400420123 @default.
- W2982346646 cites W2519543880 @default.
- W2982346646 cites W2526335337 @default.
- W2982346646 cites W2559659900 @default.
- W2982346646 cites W2564385472 @default.
- W2982346646 cites W2564574532 @default.
- W2982346646 cites W2912604276 @default.
- W2982346646 cites W2940715776 @default.
- W2982346646 cites W2950620252 @default.
- W2982346646 cites W2953424022 @default.
- W2982346646 doi "https://doi.org/10.1148/radiol.2019190887" @default.
- W2982346646 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31660801" @default.
- W2982346646 hasPublicationYear "2019" @default.
- W2982346646 type Work @default.
- W2982346646 sameAs 2982346646 @default.
- W2982346646 citedByCount "55" @default.
- W2982346646 countsByYear W29823466462019 @default.
- W2982346646 countsByYear W29823466462020 @default.
- W2982346646 countsByYear W29823466462021 @default.
- W2982346646 countsByYear W29823466462022 @default.
- W2982346646 countsByYear W29823466462023 @default.
- W2982346646 crossrefType "journal-article" @default.
- W2982346646 hasAuthorship W2982346646A5001080493 @default.
- W2982346646 hasAuthorship W2982346646A5004426985 @default.
- W2982346646 hasAuthorship W2982346646A5010411664 @default.
- W2982346646 hasAuthorship W2982346646A5028928157 @default.
- W2982346646 hasAuthorship W2982346646A5031316574 @default.
- W2982346646 hasAuthorship W2982346646A5054344119 @default.
- W2982346646 hasAuthorship W2982346646A5057889376 @default.
- W2982346646 hasAuthorship W2982346646A5058277289 @default.
- W2982346646 hasAuthorship W2982346646A5059049132 @default.
- W2982346646 hasAuthorship W2982346646A5060092330 @default.
- W2982346646 hasAuthorship W2982346646A5060609060 @default.
- W2982346646 hasAuthorship W2982346646A5076868240 @default.
- W2982346646 hasBestOaLocation W29823466461 @default.
- W2982346646 hasConcept C121608353 @default.
- W2982346646 hasConcept C126322002 @default.
- W2982346646 hasConcept C126838900 @default.
- W2982346646 hasConcept C146357865 @default.
- W2982346646 hasConcept C151730666 @default.
- W2982346646 hasConcept C188816634 @default.
- W2982346646 hasConcept C2775934546 @default.
- W2982346646 hasConcept C2776694085 @default.
- W2982346646 hasConcept C2777111374 @default.
- W2982346646 hasConcept C2777757722 @default.
- W2982346646 hasConcept C2778292576 @default.